Hi bedger great post thanks. Have you got any idea if there was an Adcomm for ruxolitinib approval and if so is there any FDA ODAC briefing documents for that meeting? Would be great to make a comparison. Cheers
- Forums
- ASX - By Stock
- MSB
- FDA ODAC Meeting Material discussion analysis
FDA ODAC Meeting Material discussion analysis, page-65
-
- There are more pages in this discussion • 427 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.01 |
Change
-0.015(1.47%) |
Mkt cap ! $1.153B |
Open | High | Low | Value | Volume |
$1.02 | $1.04 | 99.8¢ | $3.538M | 3.483M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 22086 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.01 | 136244 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 189108 | 1.000 |
14 | 260614 | 0.995 |
20 | 460393 | 0.990 |
12 | 619522 | 0.985 |
10 | 1041926 | 0.980 |
Price($) | Vol. | No. |
---|---|---|
1.005 | 49414 | 25 |
1.010 | 99135 | 16 |
1.015 | 95294 | 11 |
1.020 | 99373 | 12 |
1.025 | 132151 | 8 |
Last trade - 15.51pm 01/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |